Generation bio presents preclinical data demonstrating broad potential of gene therapy platform at asgct and reports first quarter financial results

Durable, therapeutically relevant levels of anti-sars-cov-2 spike antibodies produced from the liver in a mouse model

GBIO Ratings Summary

GBIO Quant Ranking